Medical
Orgenesis Receives Up to $5 Million Investment from Williamsburg Venture Holdings to Enhance CGT Platform
Orgenesis Inc. (OTCQX:ORGS), a global biotech company focused on advancing cell and gene therapies (CGT), has secured an equity investment of up to $5 million...
NanoViricides Partners with CRO to Advance Phase II Clinical Trials for NV-387
NanoViricides, Inc. (NYSE American: NNVC), based in Shelton, Connecticut, has announced a significant step in its clinical development pipeline by engaging a Clinical Research Organization...
Innovative Clinical Trial Utilizes Parsortix System to Advance Cancer Treatment
A recent clinical trial has unveiled promising data for a novel approach to cancer treatment, leveraging the Parsortix system to identify patients with highly metastatic...
Silo Pharma Strengthens Intellectual Property with New Provisional Patent for PTSD Treatment
Silo Pharma, Inc. (Nasdaq: SILO), a biopharmaceutical company focused on developing innovative therapeutics, has recently filed a provisional patent application with the U.S. Patent and...
CS Diagnostics Corp. Unveils MEDUSA with U.S. Launch of Innovative Disinfection Solution
CS Diagnostics Corp. (OTCQB: CSDX) has officially launched its innovative smart disinfectant product, MEDUSA, in the U.S. market. This next-generation disinfectant is engineered to elevate...
Kairos Pharma – A Business Update and Future Outlook
Kairos Pharma Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, has released an insightful update detailing its business progress and future objectives for 2025. The...
New Survey Reveals Cannabis Edibles Outpace Traditional Sleep Aids
A recent survey conducted by The Harris Poll for Green Thumb Industries’ (CSE: GTII, OTCQX: GTBIF) cannabis brand incredibles has unveiled a significant shift in...
Calidi Biotherapeutics to Showcase Innovative Systemic Virotherapy Data at AACR 2025
Calidi Biotherapeutics Inc. (NYSE American: CLDI), a clinical-stage biotechnology firm focused on developing advanced antitumor virotherapies, has announced that its research abstract titled “Development of...
Calidi Biotherapeutics Secures $4.25 Million in Public Offering to Advance Cancer Immunotherapy
Calidi Biotherapeutics, Inc. (NYSE AMERICAN: CLDI), a clinical-stage biotechnology firm specializing in targeted immunotherapies, has successfully priced its public offering of 5,000,000 shares of common...
Vaso Corporation Strengthens Leadership Team with Key Appointments
Vaso Corporation (OTCQX: VASO), a prominent player in human capital, information technology, and MedTech, has announced significant changes to its executive leadership team and Board...
